TechNavio recognizes the following companies as the key players in the Global Stem Cell Products Market: Baxter International Inc., DePuy Inc., Medtronic Inc., Stryker Corp., and Zimmer Holdings Inc.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”A new set of rules and regulations was implemented by the European Union on advanced therapy medicinal products (ATMPs) in 2011. According to the new regulations, stem cell products would be covered in the legislation for ATMPs. Eucomed, which represents the Medical Technology industry in Europe, is involved in amending the regulation and the existing directives for medical devices to include features of regenerative medicine pertaining to medical devices. The legislation focuses on patient safety while allowing adequate options for innovations.”
According to the report, the Global Stem Cell Products market is driven by numerous factors, one of which is the significant developments in R and D. Most of the applications of stem cells are in the nascent stage. Therefore, established vendors are investing heavily in R and D to evolve by having more patents in the Global Stem Cell Products market.
Further, the report states that one of the major challenges is the stringent regulations imposed on stem cell products. A number of controls on product claims and usage are restricting the introduction of newer stem cell products in the market.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are 3DM Inc., Aastrom Biosciences Inc., Advanced Cell Technology Inc., Aldagen Inc., Angioblast Systems Inc., Arteriocyte Inc., Athersys Inc., BioE Corp., Bioheart Inc., BioTime Inc., Brainstorm Cell Therapeutics Inc., Capricor Inc., Cardio3 BioSciences SA, Cellartis AB, Cellerant Therapeutics Inc., Cellular Dynamics International Inc., Cytori Therapeutics Inc., Forticell Bioscience Inc., Gamida Cell Ltd., GlobalStem Inc., Hybrid Organ GmbH, IntelliCell BioSciences Inc., International Stem Cell Corp., Juventas Therapeutics Inc., Medistem Inc., Mesoblast Ltd., NeoStem Inc.,
Neuralstem Inc., Osiris Therapeutics Inc., PharmaStem Therapeutics Inc., Plureon Corp., ReNeuron Group plc, RhinoCyte Inc., StemCells Inc., Stemcell Technologies SARL, Stem Cell Therapeutics Corp., Stemedica Cell Technologies Inc., Stemina Biomarker Discovery Inc., TiGenix NV, Verastem Inc., ViaCyte Inc., and Vitro Diagnostics Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-stem-cell-products-market-2012-2016
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Engineering market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report -Global Stem Cell Products Market 2012-2016
